BioSpace News Archive

Simulations Plus, Inc. (Nasdaq: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief executive officer Shawn O’Connor will present at the 15th Annual Needham Virtual Technology & Media Conference on Wednesday, May 20, at 10:00 a.m. ET.

Redrock Biometrics announces today that it has been selected by FalconPro Technology Co., a worldwide leader in barcode technology, to co-develop a tokenless large-scale palm-based biometric identification solution for mass transportation and payments.

Optina Diagnostics announces today that it received 510(k) clearance for its ophthalmic camera, the Mydriatic Hyperspectral Retinal Camera (MHRC-C1), by the U.S. Food and Drug Administration (FDA)

Supporting the printing and graphic arts industry for over 70 years, Oxytech Systems is helping companies like SG360° keep their operations running by using its ultraviolet light technology to quickly and efficiently sanitize their facilities against COVID-19.

Bexion Pharmaceuticals announced today that the following three abstracts submitted to the 2020 American Society of Clinical Oncology (ASCO) have been accepted for oral or poster presentation: Oral Pre

Micro Labs USA , Inc. and Saptalis Pharmaceuticals, LLC. are strengthening their association with the launch of Metformin Oral Solution in the US market. Metformin Oral Solutio

Novocure (NASDAQ: NVCR), a global oncology company with a proprietary platform therapy called Tumor Treating Fields, and Zai Lab Limited (NASDAQ: ZLAB), an innovative commercial stage biopharmaceutical company, today announced that the China National Medical Products Administration (NMPA) has approved the Marketing Authorization Application (MAA) for Optune in combination with temozolomide for the treatment of patients with newly diagnosed glioblastoma

Pharmaceutical Executive®, a multimedia platform for industry leaders to exchange experiences and insights about innovative business and marketing ideas, is proud to announce the honorees of the 2020 Emerging Pharma Leaders awards program

Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced that Chief Executive Officer Alistair Macdonald and Chief Financial Officer Jason Meggs are scheduled to present at the UBS Virtual Global Healthcare Conference on Tuesday, May 19, 2020, at 9:10 a.m. ET.

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that Executive Chairman Robert J. Coury and President Rajiv Malik will present at the 2020 RBC Capital Markets’ Virtual Global Healthcare Conference on Tuesday, May 19, 2020 at 8 a.m. ET.